Brighton Jones LLC’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,266
Closed -$55.7K 945
2025
Q1
$55.7K Sell
11,266
-100
-0.9% -$318 ﹤0.01% 688
2024
Q4
$33.4K Hold
11,366
﹤0.01% 675
2024
Q3
$53.6K Sell
11,366
-7,070
-38% -$31.9K ﹤0.01% 568
2024
Q2
$71K Hold
18,436
﹤0.01% 616
2024
Q1
$98.6K Buy
18,436
+3,939
+27% +$18.5K ﹤0.01% 605
2023
Q4
$61.9K Sell
14,497
-899
-6% -$2.76K ﹤0.01% 565
2023
Q3
$60.4K Buy
+15,396
New +$101K ﹤0.01% 532
2022
Q1
Sell
-9,042
Closed -$232K 548
2021
Q4
$232K Buy
+9,042
New +$282K 0.01% 452

Other funds holding TSVT

Brighton Jones LLC's TSVT Position: Q2 2025 in Review

Brighton Jones LLC sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 11,266 shares — an estimated $55.7K sold.

Brighton Jones LLC first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $232K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Brighton Jones LLC reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Brighton Jones LLC sold 11,266 2seventy bio shares in Q2 2025, an estimated $55.7K.
  • Brighton Jones LLC first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • Brighton Jones LLC's 2seventy bio position peaked at $232K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Brighton Jones LLC's 13F filing for Q2 2025, filed 31 Jul 2025.